Toggle navigation
About Us
Business Areas
R & D
Manufacturing
Beyond Business
Investors
Careers
Contact Us
Investors
Investors > FY 2012-13
Overview
Chairman's Statement
Shareholder Information
Policies or Statutory Documents
IEPF
Debentures
Amalgamation
MOA/AOA
Procedure for Dematerialisation of Shares
Archives
Credit Ratings
CSR
AGM Transcript
Annual Return
Disclosures under Regulation 46 and 62 of SEBI LODR
Financial
2023-24
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
2014-15
2013-14
2012-13
2011-12
Investors > FY 2012-13
1. Annual Report
Annual Report
2. Intimation to Stock Exchange
Shareholding Pattern Q4
Shareholding Pattern Q3
Shareholding Pattern Q2
Shareholding Pattern Q1
Quarterly Compliance Report Q4
Quarterly Compliance Report Q3
Quarterly Compliance Report Q2
Quarterly Compliance Report Q1
3. Quarterly Results
Q1 12-13
Q2 12-13
Q3 12-13
Q4 12-13
Press Release on Q1 Results
Investors Presentation
Q1, FY 2013 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q2 Results
Investors Presentation
Q2, FY 2013 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q3 Results
Investors Presentation
Q3, FY 2013 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q4 Results
Investors Presentation
Q4, FY 2013 Con call Transcript
Q4, FY 2013 Con call Transcript
Stand Alone Results
Consolidated Results
Details of Nodal Officer
Name
: Chintan Trivedi
Designation
: Company Secretary
E-mail Id
: investorservices@torrentpharma.com
IEPF Authority - Refund web page
IEPF Authority - Refund web page >>
